Biomaterials as regenerative medicine in Poly Cystic Ovarian Syndrome (PCOS) treatment

Chauhan, Nidhi; Peter, Anjali; Soni, Shringika; Rawal, Rachna; Jain, Utkarsh

doi:10.1016/j.bej.2022.108649

Cited by 3 publications

(2 citation statements)

References 107 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study looked at how well lipid-based nanoparticles that were linked to a synthetic peptide called plCSA binding peptide (plCSA-BP) could deliver methotrexate to placental cells. 170 The findings of the study demonstrate that the plCSA-BP exhibited successful adherence to nanoparticles containing methotrexate. This resulted in efficient binding to human placental syncytiotrophoblasts or mouse trophoblasts during all phases of pregnancy.…”

Section: Nanotechnology Advances For Gestational Trophoblastic Disord...mentioning

confidence: 75%

“…This means that it might be possible to use it specifically for therapeutic purposes when dealing with GTDs. This study looked at how well lipid-based nanoparticles that were linked to a synthetic peptide called plCSA binding peptide (plCSA-BP) could deliver methotrexate to placental cells . The findings of the study demonstrate that the plCSA-BP exhibited successful adherence to nanoparticles containing methotrexate.…”

Section: Applications Of Nanotechnology-mediated Drug Delivery System...mentioning

confidence: 99%

See 1 more Smart Citation

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

Acharya,

Behera,

Behera

et al. 2024

ACS Appl. Bio Mater.

View full text Add to dashboard Cite

Over the past decade, nanotechnology has seen extensive integration into biomedical applications, playing a crucial role in biodetection, drug delivery, and diagnostic imaging. This is especially important in reproductive health care, which has become an emerging and significant area of research. Global concerns have intensified around disorders such as infertility, endometriosis, ectopic pregnancy, erectile dysfunction, benign prostate hyperplasia, sexually transmitted infections, and reproductive cancers. Nanotechnology presents promising solutions to address these concerns by introducing innovative tools and techniques, facilitating early detection, targeted drug delivery, and improved imaging capabilities. Through the utilization of nanoscale materials and devices, researchers can craft treatments that are not only more precise but also more effective, significantly enhancing outcomes in reproductive healthcare. Looking forward, the future of nanotechnology in reproductive medicine holds immense potential for reshaping diagnostics, personalized therapies, and fertility preservation. The utilization of nanotechnology-driven drug delivery systems is anticipated to elevate treatment effectiveness, minimize side effects, and offer patients therapies that are not only more precise but also more efficient. This review aims to delve into the various types, properties, and preparation techniques of nanocarriers specifically designed for drug delivery in the context of reproductive disorders, shedding light on the current landscape and potential future directions in this dynamic field.

show abstract

Section: Nanotechnology Advances For Gestational Trophoblastic Disord...mentioning

confidence: 75%

Section: Applications Of Nanotechnology-mediated Drug Delivery System...mentioning

confidence: 99%

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

Acharya,

Behera,

Behera

et al. 2024

ACS Appl. Bio Mater.

View full text Add to dashboard Cite

show abstract

An insight into the state of nanotechnology-based electrochemical biosensors for PCOS detection

Chauhan,

Pareek,

Rosario

et al. 2024

Analytical Biochemistry

View full text Add to dashboard Cite

Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer

Sharma,

Patnala,

Sah

et al. 2024

Process Biochemistry

View full text Add to dashboard Cite

Biomaterials as regenerative medicine in Poly Cystic Ovarian Syndrome (PCOS) treatment

Cited by 3 publications

References 107 publications

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

An insight into the state of nanotechnology-based electrochemical biosensors for PCOS detection

Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer

Contact Info

Product

Resources

About